A case is presented of transient cerebral atrophy and hyperlipidemia in an infant with kwashiorkor.
Little is known about toxic intrauterine insults associated with hepatic changes of neonatal liver disease. Attempts to study neonatal rat hepatotoxicity by toxin injections of pregnant rats has resulted in sporadic giant cell induction. This study used a direcr route of injection of E. coli endotoxin (TOX) to investigate its hepatotoxicity and pathogenesis of neonatal hepatitis (NH). Fetal amniotic cavities of 16 day, timed-pregnant Sprague-Dawley rats were injected with TOX or with saline as controls. Five days later, fetal livers were removed and prepared for histologic evaluation. A significant increase (p<0.001) in giant cell transformatio was noted in TOX-injected fetuses (mean S fSPI. 5.01f0.61 cellslmm ) compared to controls (1.46f0.14).
A direct correlation was also noted between the number of giant cells and the concentration of injected TOX. Furthermore the percent albunin (ALB) synthesis (innnunoprecipitation of ~JC-ALB) of total protein synthesis (14~-leucine incorporation into TCAprecipitated liver homogenates) was significantly lower in TOXtreated fetuses compared to controls (p<0.02).
In addition, preliminary studies showed serum alpha fetoprotein (AFP) levels in TOX-treated animals were greater than controls. This may be due to the reversion of the damaged liver to AFP synthesis and is consistent with elevated levels of serum AFP noted in NH. These findings suggest that TOX is a reliable fetal hepatotoxic agent and may be used as a model system to study the pathogenesis of NH. There was a significant decrease in P/FFA ratio (~~0 . 0 1 ) end increase in LlFFA ratio (pc0.001) and reversal of PIL ratio (p<0.001).
In the post infusion period from 4 to 6 hours, there was a reversal of these altered ratios towards baseline values, but this change was not statistically significant. There are both quantitative and qualitative changes in plasma FFA during Intralipid infusion. These alterations reflect the fatty acid composition of Intralipid. Slow return of FFA to the normal pattern after stopping Intralipid infusion depends on the rate of ceblar uptake or metabolism of the F F~. 
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